{"DataElement":{"publicId":"7154852","version":"1","preferredName":"Myelodysplastic Syndrome Unclassifiable Disease or Disorder Subgroup Type","preferredDefinition":"A description of myelodysplastic syndrome, unclassifiable disease or disorder subgroup type.","longName":"7149783v1.0:7149785v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"7149783","version":"1","preferredName":"Myelodysplastic Syndrome Unclassifiable Disease or Disorder","preferredDefinition":"A subtype of myelodysplastic syndrome which initially lacks findings appropriate for classification into any other myelodysplastic category.  There are no specific morphologic findings.  The diagnosis can be made in the following instances: 1. in cases of refractory cytopenia with unilineage dysplasia or refractory cytopenia with multilineage dysplasia but with 1% blasts in the peripheral blood; 2: in cases of myelodysplastic syndrome with unilineage dysplasia which are associated with pancytopenia; 3: in cases with persistent cytopenia (s) with 1% or fewer blasts in the blood and fewer than 5% in the bone marrow, unequivocal dysplasia in less than 10% of the cells in one or more myeloid lineages, and cytogenetic abnormalities considered as presumptive evidence of myelodysplastic syndrome. (WHO, 2008)_Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","longName":"7149786v1.0:2239878v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"7149786","version":"1","preferredName":"Myelodysplastic Syndrome, Unclassifiable","preferredDefinition":"A subtype of myelodysplastic syndrome which initially lacks findings appropriate for classification into any other myelodysplastic category.  There are no specific morphologic findings.  The diagnosis can be made in the following instances: 1. in cases of refractory cytopenia with unilineage dysplasia or refractory cytopenia with multilineage dysplasia but with 1% blasts in the peripheral blood; 2: in cases of myelodysplastic syndrome with unilineage dysplasia which are associated with pancytopenia; 3: in cases with persistent cytopenia (s) with 1% or fewer blasts in the blood and fewer than 5% in the bone marrow, unequivocal dysplasia in less than 10% of the cells in one or more myeloid lineages, and cytogenetic abnormalities considered as presumptive evidence of myelodysplastic syndrome. (WHO, 2008)","longName":"C8648","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myelodysplastic Syndrome, Unclassifiable","conceptCode":"C8648","definition":"A subtype of myelodysplastic syndrome which initially lacks findings appropriate for classification into any other myelodysplastic category.  There are no specific morphologic findings.  The diagnosis can be made in the following instances: 1. in cases of refractory cytopenia with unilineage dysplasia or refractory cytopenia with multilineage dysplasia but with 1% blasts in the peripheral blood; 2: in cases of myelodysplastic syndrome with unilineage dysplasia which are associated with pancytopenia; 3: in cases with persistent cytopenia (s) with 1% or fewer blasts in the blood and fewer than 5% in the bone marrow, unequivocal dysplasia in less than 10% of the cells in one or more myeloid lineages, and cytogenetic abnormalities considered as presumptive evidence of myelodysplastic syndrome. (WHO, 2008)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9CEB658A-2ED3-0E34-E053-F662850ABC67","latestVersionIndicator":"Yes","beginDate":"2020-01-24","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-01-24","modifiedBy":"ONEDATA","dateModified":"2020-01-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2239878","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FA7953-827F-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-24","modifiedBy":"ONEDATA","dateModified":"2005-06-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9CEB47BF-F6F6-186C-E053-F662850A46CF","latestVersionIndicator":"Yes","beginDate":"2020-01-24","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-01-24","modifiedBy":"MALUMK","dateModified":"2020-12-03","changeDescription":"Released. 12/03/2020 KMM; Released. 11/11/2020 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7149785","version":"1","preferredName":"Myelodysplastic Syndrome, Unclassifiable Subgroup Type","preferredDefinition":"A subtype of myelodysplastic syndrome which initially lacks findings appropriate for classification into any other myelodysplastic category.  There are no specific morphologic findings.  The diagnosis can be made in the following instances: 1. in cases of refractory cytopenia with unilineage dysplasia or refractory cytopenia with multilineage dysplasia but with 1% blasts in the peripheral blood; 2: in cases of myelodysplastic syndrome with unilineage dysplasia which are associated with pancytopenia; 3: in cases with persistent cytopenia (s) with 1% or fewer blasts in the blood and fewer than 5% in the bone marrow, unequivocal dysplasia in less than 10% of the cells in one or more myeloid lineages, and cytogenetic abnormalities considered as presumptive evidence of myelodysplastic syndrome. (WHO, 2008)_Something distinguishable as an identifiable class based on common qualities._A subdivision of a larger group with members often exhibiting similar characteristics._A subtype of myelodysplastic syndrome which initially lacks findings appropriate for classification into any other myelodysplastic category.  There are no specific morphologic findings.  The diagnosis can be made in the following instances: 1. in cases of refractory cytopenia with unilineage dysplasia or refractory cytopenia with multilineage dysplasia but with 1% blasts in the peripheral blood; 2: in cases of myelodysplastic syndrome with unilineage dysplasia which are associated with pancytopenia; 3: in cases with persistent cytopenia (s) with 1% or fewer blasts in the blood and fewer than 5% in the bone marrow, unequivocal dysplasia in less than 10% of the cells in one or more myeloid lineages, and cytogenetic abnormalities considered as presumptive evidence of myelodysplastic syndrome. (WHO, 2008)_A subdivision of a larger group with members often exhibiting similar characteristics.","longName":"7149785v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"MDS-U based on defining cytogenetic abnormality","valueDescription":"Myelodysplastic Syndrome, Unclassifiable, Based on Defining Cytogenetic Abnormality","ValueMeaning":{"publicId":"7158727","version":"1","preferredName":"Myelodysplastic Syndrome, Unclassifiable, Based on Defining Cytogenetic Abnormality","longName":"7158727","preferredDefinition":"Myelodysplastic syndrome, unclassifiable characterized by persistent cytopenia (s) with 1 percent or fewer blasts in the blood and fewer than 5% in the bone marrow, unequivocal dysplasia in less than 10 percent of the cells in one or more myeloid lineages, and cytogenetic abnormalities considered as presumptive evidence of myelodysplastic syndrome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myelodysplastic Syndrome, Unclassifiable, with Defining Cytogenetic Abnormality","conceptCode":"C168678","definition":"Myelodysplastic syndrome, unclassifiable characterized by persistent cytopenia (s) with 1 percent or fewer blasts in the blood and fewer than 5% in the bone marrow, unequivocal dysplasia in less than 10 percent of the cells in one or more myeloid lineages, and cytogenetic abnormalities considered as presumptive evidence of myelodysplastic syndrome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DB2D1A8-3A81-34ED-E053-F662850A91CA","latestVersionIndicator":"Yes","beginDate":"2020-02-04","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-02-04","modifiedBy":"ONEDATA","dateModified":"2020-02-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9DB2D1A8-3A9A-34ED-E053-F662850A91CA","beginDate":"2020-01-28","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-02-04","modifiedBy":"ONEDATA","dateModified":"2020-02-04","deletedIndicator":"No"},{"value":"MDS-U with 1% blood blasts","valueDescription":"Myelodysplastic Syndrome, Unclassifiable, With 1 Percent Blasts","ValueMeaning":{"publicId":"7158728","version":"1","preferredName":"Myelodysplastic Syndrome, Unclassifiable, With 1 Percent Blasts","longName":"7158728","preferredDefinition":"Myelodysplastic syndrome, unclassifiable characterized by refractory cytopenia with unilineage dysplasia or refractory cytopenia with multilineage dysplasia but with 1 percent blasts in the peripheral blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myelodysplastic Syndrome, Unclassifiable, with 1 Percent Blasts","conceptCode":"C168677","definition":"Myelodysplastic syndrome, unclassifiable characterized by refractory cytopenia with unilineage dysplasia or refractory cytopenia with multilineage dysplasia but with 1 percent blasts in the peripheral blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DB2D1A8-3AA6-34ED-E053-F662850A91CA","latestVersionIndicator":"Yes","beginDate":"2020-02-04","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-02-04","modifiedBy":"ONEDATA","dateModified":"2020-02-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9DB2D1A8-3ABF-34ED-E053-F662850A91CA","beginDate":"2020-01-24","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-02-04","modifiedBy":"ONEDATA","dateModified":"2020-02-04","deletedIndicator":"No"},{"value":"MDS-U with single lineage dysplasia and pancytopenia","valueDescription":"Myelodysplastic Syndrome, Unclassifiable, with Single Lineage Dysplasia","ValueMeaning":{"publicId":"7158729","version":"1","preferredName":"Myelodysplastic Syndrome, Unclassifiable, with Single Lineage Dysplasia","longName":"7158729","preferredDefinition":"Myelodysplastic syndrome, unclassifiable characterized by unilineage dysplasia and associated pancytopenia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myelodysplastic Syndrome, Unclassifiable, with Single Lineage Dysplasia","conceptCode":"C168681","definition":"Myelodysplastic syndrome, unclassifiable characterized by unilineage dysplasia and associated pancytopenia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DB2D1A8-3ACB-34ED-E053-F662850A91CA","latestVersionIndicator":"Yes","beginDate":"2020-02-04","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-02-04","modifiedBy":"ONEDATA","dateModified":"2020-02-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9DB2D1A8-3AE4-34ED-E053-F662850A91CA","beginDate":"2020-01-28","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-02-04","modifiedBy":"ONEDATA","dateModified":"2020-02-04","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7203668","version":"1","preferredName":"Myelodysplastic Syndrome, Unclassifiable Subgroup Type","preferredDefinition":"A subtype of myelodysplastic syndrome which initially lacks findings appropriate for classification into any other myelodysplastic category.  There are no specific morphologic findings.  The diagnosis can be made in the following instances: 1. in cases of refractory cytopenia with unilineage dysplasia or refractory cytopenia with multilineage dysplasia but with 1% blasts in the peripheral blood; 2: in cases of myelodysplastic syndrome with unilineage dysplasia which are associated with pancytopenia; 3: in cases with persistent cytopenia (s) with 1% or fewer blasts in the blood and fewer than 5% in the bone marrow, unequivocal dysplasia in less than 10% of the cells in one or more myeloid lineages, and cytogenetic abnormalities considered as presumptive evidence of myelodysplastic syndrome. (WHO, 2008):A subdivision of a larger group with members often exhibiting similar characteristics.:Something distinguishable as an identifiable class based on common qualities.","longName":"C8648:C25693:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myelodysplastic Syndrome, Unclassifiable","conceptCode":"C8648","definition":"A subtype of myelodysplastic syndrome which initially lacks findings appropriate for classification into any other myelodysplastic category.  There are no specific morphologic findings.  The diagnosis can be made in the following instances: 1. in cases of refractory cytopenia with unilineage dysplasia or refractory cytopenia with multilineage dysplasia but with 1% blasts in the peripheral blood; 2: in cases of myelodysplastic syndrome with unilineage dysplasia which are associated with pancytopenia; 3: in cases with persistent cytopenia (s) with 1% or fewer blasts in the blood and fewer than 5% in the bone marrow, unequivocal dysplasia in less than 10% of the cells in one or more myeloid lineages, and cytogenetic abnormalities considered as presumptive evidence of myelodysplastic syndrome. (WHO, 2008)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Subgroup","conceptCode":"C25693","definition":"A subdivision of a larger group with members often exhibiting similar characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0AEEEE8-31F0-23B5-E053-F662850AB105","latestVersionIndicator":"Yes","beginDate":"2020-03-12","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-03-12","modifiedBy":"ONEDATA","dateModified":"2020-03-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9CEB5B1D-32CC-0916-E053-F662850A68F6","latestVersionIndicator":"Yes","beginDate":"2020-01-24","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-01-24","modifiedBy":"MALUMK","dateModified":"2020-12-03","changeDescription":"Released. 12/03/2020 KMM; Released. 12/03/2020 KMM; Released. 12/03/2020 KMM; .Released 11/11/2020 KMM; Updated PVs for 2402r5. 01/28/2020 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"TDIS_MDS_mds_u_subtyp","type":"NMDP_FN","context":"NHLBI"},{"name":"TDIS_MDS_mds_u_subtype","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the myelodysplastic","type":"Preferred Question Text","description":"What was the myelodysplastic syndrome, unclassifiable disease or disorder subgroup type?","url":null,"context":"NHLBI"},{"name":"Specify Myelodysplastic syndrome, unclassifiable (MDS-U)","type":"Application Standard Question Text","description":"Specify Myelodysplastic syndrome, unclassifiable (MDS-U)","url":null,"context":"NHLBI"},{"name":"Specify Myelodysplastic syndrome, unclassifiable (MDS-U)","type":"Alternate Question Text","description":"Specify Myelodysplastic syndrome, unclassifiable (MDS-U)","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D396D18-F04C-32D0-E053-F662850A3CF7","latestVersionIndicator":"Yes","beginDate":"2020-01-28","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-01-28","modifiedBy":"MALUMK","dateModified":"2020-11-11","changeDescription":"Released. 11/11/2020 KMM; System generated def displayed as alt def. 03/12/2020 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}